Biopsy Devices Market Expected to Hit $12.6 Billion by 2028

-

The global biopsy devices market is on a trajectory of remarkable growth, projected to reach USD 12.6 billion by 2028 from USD 6.6 billion in 2023, with a notable CAGR of 14.0% from 2023 to 2028. This substantial growth is driven by advancements in medical technology, resulting in the creation of increasingly accurate and less invasive biopsy instruments. These innovations mitigate patient discomfort and expedite recovery periods, making them pivotal in the field of diagnostics.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132886515

Understanding Biopsy Devices Market Dynamics

Needle Based Biopsy Instruments: A Growing Segment

The market is segmented into Needle Based Biopsy Instruments, Localization Wire, Procedure Tray, Biopsy Table, and other biopsy products. Among these, the Needle Based Biopsy Instruments segment is anticipated to register the highest growth rate over the forecast period.

Breast Biopsy: A Leading Application

In terms of applications, the breast biopsy segment is expected to register significant growth over the forecast period. Biopsy devices are vital tools used to extract tissue samples for diagnostic purposes. They are utilized by various healthcare professionals and organizations, including physicians, surgeons, and medical practitioners. The breast biopsy segment, in particular, is anticipated to witness substantial growth.

Hospitals and Breast Care Centers: Key End Users

The hospitals and breast care centers segment accounted for the largest share of the biopsy devices market in 2022. As cancer awareness and screening programs expand, more patients are seeking diagnostic services in hospitals and specialized breast care centers. Advancements in imaging technologies and screening techniques have led to an increased demand for biopsy procedures in these settings to confirm diagnoses and plan personalized treatment strategies.

Asia Pacific: A Region of Significant Growth

The Asia Pacific biopsy devices market is poised to register significant growth from 2023 to 2028. Factors such as the increasing patient population, rising geriatric population, rapid economic growth, and increasing disposable income are driving market growth in APAC countries. The region is witnessing a rise in healthcare investment and expenditure, offering significant growth opportunities for key players.

Top Key Players of the Biopsy Devices Industry

Prominent players in the biopsy devices market include Becton, Dickinson and Company (U.S.), Devicor Medical Products, Inc. (Leica Biosystems) (Germany), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), and Hologic, Inc. (US).

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132886515

Conclusion

The biopsy devices market plays a crucial role in modern diagnostics, offering accurate and minimally invasive solutions for tissue sampling. With advancements in technology and growing awareness about cancer screening and early detection, the demand for biopsy devices is expected to rise significantly. Key players in the industry are actively investing in innovation and expansion, ensuring the continuous evolution of biopsy devices to meet the changing needs of healthcare providers and patients worldwide.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in their ow
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d
Read more

Stable Isotope Labeled Compounds Market Growth: Trends and Opportunities

-
The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0% between 2019 and 2024. The growth of this market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, the rising prevalence of cancer, and rising proteomics research. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199 The H-2 labeled compounds segment accounted for the largest share of the stable isotope labeled compounds market. Based on type, the stable isotope labeled compounds industry is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest share of the stable isotope-labeled compounds market in 2019. The large share of this
Read more